Red Queen Bio

Red Queen Bio specializes in the development of biosecurity technologies. Founded by a team with a focus on leveraging AI in biodefense, their headquarters is located in the United States.Red Queen Bio specializes in developing advanced biosecurity solutions that leverage artificial intelligence to counteract biological threats. Their core offerings include a countermeasure design pipeline utilizing leading AI models, lab automation, and reinforcement learning to create medical countermeasures against AI-enabled biothreats. The company collaborates with frontier laboratories to pre-build defenses that are scalable with computational resources, facilitating rapid responses to emerging biological risks. The company’s business transactions are structured around partnerships with governmental entities and biopharma companies. Revenue generation occurs through investments in cooperative projects that align with client objectives, focusing on creating tailored defensive solutions. The company aims to develop new products focused on enhancing biosecurity measures, targeting expansion into international markets over the next few years, further promoting robust defense infrastructures against biological threats.

1. Seed

   Nov 13, 2025

   Amount

   $15M

   Investors

   Locked